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DDW 2016: Basic and
Translational Activities and
Interests of the AGA Councilelcome to the May issue of Cellular and MolecularWGastroenterology and Hepatology. With Digestive
Disease Week® (DDW) just around the corner, we have
compiled the following section highlights and meeting
guides prepared by the American Gastroenterological As-
sociation (AGA) Council Sections listed later. We hope that
this feature helps support the basic and translational
research communities within the AGA, as well as assisting
our readers in taking advantage of the vast array of offerings
at DDW.
Thanks very much to the section chairs and vice chairs,
as well as the AGA staff who helped prepared this compi-
lation, and to all of you for your support of Cellular and
Molecular Gastroenterology and Hepatology.
Looking forward to seeing you in San Diego!
JERROLD R. TURNER, MD, PhD, AGAF
Editor-in-Chief
DDW 2016 for the AGA Council
sections are as follows:
Cellular and Molecular Gastroenterology Section
Gastrointestinal Oncology Section
Growth, Development and Child Health Section
Immunology, Microbiology and Inﬂammatory Bowel
Diseases Section
Intestinal Disorders Section
Liver and Biliary Section
Neurogastroenterology and Motility Section
Obesity, Metabolism and Nutrition Section
Pancreatic Disorders Section
Cellular and Molecular
Gastroenterology Section
Charalabos Pothoulakis, MD, and
Linda C. Samuelson, PhDIntroduction
The AGA Council section “Cellular and Molecular
Gastroenterology” (CMG) has broad interests in the basic
mechanisms underlying digestive diseases and gastroin-
testinal physiology. The recent name change from our
past name, “Regulatory Peptides, Cell Signaling, and Mo-
lecular Biology,” reﬂects the broad basic science focus of
our section. From its origins in the study of gastrointes-
tinal hormones, the section’s membership has interests
representing many areas of cutting-edge science,
including growth factors and stem cells, cellular differ-
entiation in the gastrointestinal (GI) tract, epigenetics,Cellumechanisms of receptor function, basic physiology and
cell biology, luminal chemosensing, intestinal inﬂamma-
tion, and mucosal injury and healing. CMG strives to invite
outside speakers who are leading scientists in their ﬁelds
to present forward-looking scientiﬁc programming at
DDW.
We have an exciting line-up for DDW 2016. CMG will
sponsor a distinguished abstract plenary session, 4
research symposia, 7 research fora, and 7 poster sessions.
We had 189 abstracts submitted to our section, a marked
increase over past years. We look forward to seeing you at
DDW!
Research Fora
Saturday, May 21, 2016: “Organoid Models of Gastro-
intestinal Disorders” and “Microbiome Determinants of C
difﬁcile Infection” (including an overview by Tor Savidge).
Sunday, May 22, 2016: “Transcriptional and Epigenetic
Regulation of GI Cancers.”
Monday, May 23, 2016: “Receptors and Enteric Neuro-
sciences,” “Mechanisms Regulating GI Epithelial Cell
Homeostasis,” and “Stem Cell Biology.”
Tuesday, May 23, 2016: “Inﬂammatory Signaling in the
GI Tract.”
Distinguished Abstract Plenary
We will hold our section’s distinguished abstract plenary
session on Saturday, May 21, 2016. Six outstanding ab-
stracts will focus on themes of stem cells, cell signaling, and
cellular differentiation in health and disease. At this session,
the CMG section also will present the Cellular and Molecular
Gastroenterology Section Research Mentor Award to James
R. Goldenring, MD, PhD, AGAF.
Symposia
Saturday, May 21, 2016: “Genetic and Epigenetic
Drivers of Colorectal Cancer.” This symposium covers
epigenetic mechanisms of intestinal growth and colon can-
cer, including the role of long-noncoding RNAs, the impact
of RNA-binding proteins, and a current view of the driver
mutations responsible for tumor initiation and progression.
Presenters include: Dimitrios Iliopoulos, Blair Madison, and
William M. Grady.
Sunday, May 22, 2016: “Intestinal Stem Cell Niche.”
This symposium presents a current view of the microen-
vironment that regulates intestinal stem cells, including
an appreciation of the signaling pathways that regulate
stem cell self-renewal, proliferation, and differentiation,
as well as the key epithelial and mesenchymal cell pop-
ulations that support stem cell homeostasis. Presenters
include: Calvin Kuo, Linda C. Samuelson, and Klaus H.
Kaestner.
Sunday, May 22, 2016: “Bile Acid Signaling in Health
and Disease.” This symposium will examine the physiology
and pathophysiology of bile acids, with experts in the ﬁeldlar and Molecular Gastroenterology and Hepatology 2016;2:241–250
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for regulation of metabolism and inﬂammatory processes,
and impact in disease processes during pregnancy. Pre-
senters include: Ronald M. Evans, Kristina Schoonjans, and
Catherine Williamson.
Monday, May 23, 2016: “Gastrointestinal and Metabolic
Complications of Obesity.” This symposium explores meta-
bolic signaling and disease processes associated with
obesity, including signaling mechanisms regulating lipid
metabolism and obesity-related changes in gastrointestinal
motility, and the role of the inﬂammasome in metabolic
signaling. Presenters include: Simon W. Beaven, Shanthi
Srinivasan, and Matam Vijay-Kuman.
Poster Sessions
Finally, CMG is sponsoring 7 poster sessions.
Saturday, May 21, 2016: “Cancer Genetics and Biology,”
“Transcriptional and Epigenetic Regulation of GI Function,”
and “Stem Cells and Organoids.”
Sunday, May 22, 2016: “Receptor Signaling” and
“Metabolic Signaling.”
Monday, May 23, 2016: “Clostridium difﬁcile Infection:
Pathophysiology, Diagnosis, and Management.”
Tuesday, May 24, 2016: “Cell Signaling and
Inﬂammation.”
Gastrointestinal Oncology Section
William M. Grady, MD, AGAF, and
Rhonda F. Souza, MD, AGAF
Introduction
The GI Oncology section focuses on themes in oncology
that pertain to multiple cancer types and is not restricted to
a single organ site. Our membership is diverse, with basic
scientists engaged in the investigation of fundamental
mechanisms of cancer as well as organ-based cancer
research; translational scientists involved in the application
of basic ﬁndings to the clinical management of people at risk
for cancer, people with premalignant lesions, or people with
GI cancer; outcomes and epidemiology researchers, and
clinical scientists interested in cancer prevention, screening,
and new imaging technologies. We have more than 2000
members in our section, with recent growth seen in our
international members, particularly in young international
members.
Research Fora
The GI Oncology section has exciting research fora
encompassing clinical, translational, and basic science. Our
“Must See” research sessions for DDW 2016 are
highlighted.
Saturday, May 21, 2016: “Barrett’s Esophagus: New
Models, New Signaling Pathways, and the Value of Acid
Suppression.” This translational research forum covers
novel models to study Barrett’s esophagus, new insights
into molecular factors regulating the behavior of Barrett’s
esophagus, and the pros and cons of acid suppression for
this condition. For anyone with an interest in Barrett’sesophagus a “do not miss” summary talk putting these new
ﬁndings into the current context of our knowledge of Bar-
rett’s esophagus will be delivered by Dr Stuart Spechler, an
international expert in esophageal diseases, especially Bar-
rett’s esophagus.
Sunday, May 22, 2016: “Inﬂammation-Associated
Gastric and Colon Carcinogenesis.” This basic science
research forum includes a set of exciting studies that
advance our understanding of basic mechanisms involved
in inﬂammation-associated cancer. The topics cover the
role of inﬂammatory signaling in immune cell activation
and novel roles of inﬂammatory factors in cancer biology.
In addition, the impact of targeting “inﬂammation-acti-
vated receptors” as a potential therapeutic target will be
presented. This session will occur on Sunday in the new
Basic Science Themed Track entitled “Inﬂammation and GI
Cancers.”
Tuesday, May 24, 2016: “Endoscopic and Molecular
Colon Cancer Screening and Surveillance: Beneﬁts and Lat-
est Advances.” This translational research forum covers the
pros and cons of currently available colon cancer screening
tests including endoscopy, fecal occult blood testing/FIT,
and molecular marker assays (eg, Cologuard), and will
provide information on the latest advances in molecular
strategies applicable to both screening and surveillance of
colon cancer.
Distinguished Abstract Plenary
Monday, May 23, 2016: This session features some of
the most highly rated abstracts submitted to DDW 2016
and will present the latest advances in the area of GI
Oncology clinical and basic science research. Topics will
cover advances in our understanding of the risk of
colorectal cancer after a negative colonoscopy, and of the
role of diet, microRNAs, and bacteria on colorectal can-
cer development. Other topics will include the role of
gene fusions in esophageal adenocarcinoma and circu-
lating neuroendocrine gene transcripts that predict the
progression and recurrence of these tumors after
surgery.
Symposia
Sunday, May 22, 2016: “GRG SPRING SYMPOSIUM:
Inﬂammation in Cancer: Friend or Foe?” This cutting edge
translational symposium will host a panel of international
experts discussing inﬂammation as a “double-edge sword”
in cancer. Dr Michael Karin will present “Inﬂammatory
Pathways and Cancer Development” and Dr Michael Morse
will present “Cancer Vaccines Making a Comeback.” This is a
“must see” session for investigators interested in both
inﬂammation and cancer.
Monday, May 23, 2016: “Gastric Intestinal Metaplasia:
What it Is and What to Do.” This sensational clinical sym-
posium features a panel of international experts covering
topics relevant to the practical management of patients with
gastric intestinal metaplasia. Topics include the diagnosis of
gastric intestinal metaplasia, the role of endoscopic and
advanced endoscopic imaging in the surveillance of this
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progression to cancer.
Tuesday, May 24, 2016: “Updated Understanding and
Approach to Managing Neoplastic Cysts/IPMNs [Intra-
ductal Papillary Mucinous Neoplasm] of the Pancreas.”
This exciting translational symposium features a panel of
international experts covering topics relevant to the
practice and management of patients with neoplastic
cysts and IPMNs of the pancreas. Topics include the
identiﬁcation and evaluation of pancreatic cysts and cyst
ﬂuid analysis, and application of recommendations from
the 2012 Fukuoka and 2015 AGA guidelines to your
practice.
State of the Art
Five of our Research Fora will culminate in State-of-the-
Art talks given by leading experts in the ﬁeld.
Saturday, May 21, 2016: “Multifaceted Roles of RNAs in
Tumorigenesis” by Dr Nicholas O. Davidson. Dr Davidson is
an internationally recognized leader in the regulation of
RNA expression, and his talk will conclude the session
entitled, “RNAs and Their Binding Proteins: Multifaceted
Roles in Tumorigenesis.”
Sunday, May 22, 2016: “Overview of Biomarkers for GI
Cancers with Focus on Emerging Biomarkers Nearing Clin-
ical Use” by Dr Joseph Sung. This talk is being given by an
international authority in biomarkers who has been leading
the ﬁeld of biomarker development for GI cancers and will
conclude the session entitled, “Biomarkers for Detection,
Treatment, and Prognosis of GI Cancers.”
Monday, May 23, 2016: “Acinar to Ductal Metaplasia:
Transdifferentiation or Dedifferentiation” by Dr Jason
Mills. This talk is given by an internationally recognized
thought leader in metaplasia and will conclude the session
entitled, “Pancreatic Cancers: Advances in Biology and
Therapeutics.”
“Hereditary and Familial Contributions to Colorectal
Cancer in the Young” by Dr Dennis Ahnen. This talk is
being given by an international leader in the ﬁeld of he-
reditary cancer research and will conclude the session
entitled, “Cancer Susceptibility and Familial Cancer
Syndromes.”
“Overview and Implications for Understanding Gastric
Diseases” by Dr Richard M. Peek. Dr Peek has led the ﬁeld of
gastric cancer research and his talk will conclude the ses-
sion entitled, “Gastric Neoplasms: Precursors, Biology,
Diagnosis, and Therapy.”
Other Events
GIONC 2016 Research Mentor Award Recipient: John
Carethers, MD, AGAF. This award will be presented at the
start of the GIONC Distinguished Abstract Plenary Session
on Monday, May 23, 2016. Please stop by and congratulate
Dr Carethers on this well-deserved award as an outstanding
mentor.
GIONC Business Meeting. Our business meeting will be
held immediately after the GIONC Distinguished Abstract
Plenary Session on Monday, May 23, 2016.Growth, Development, and Child
Health Section
Noah F. Shroyer, PhD, and
Maria Oliva-Hemker, MD
Introduction
The Growth, Development, and Child Health (GDCH)
section is the home for pediatrics and developmental
biology within the AGA. The membership of the GDCH has
the most diverse range of digestive health interests within
the AGA, representing the interests of pediatrics within all
digestive organ systems as well as basic science related to
growth, development, and pediatrics.
Research Fora
The GDCH section will feature 7 fora at DDW 2016, the
majority of which will showcase both abstract and invited
presentations.
Saturday, May 21, 2016: “Pediatric Intestinal Disor-
ders,” “Molecular Mechanisms of Growth and Development
of the GI Tract,” and “Microbial Dysbiosis in Pediatric
Disease.”
Sunday, May 22, 2016: “Pediatric Functional and
Motility Disorders.”
Monday, May 23, 2016: “Developmental Biology of the
GI Tract” and “Pediatric Inﬂammatory Bowel Diseases.”
Tuesday, May 24, 2016: “Functional and Motility
Disorders in Children: Inﬂuence of Microbes and
Inﬂammation.”
Symposia
The GDCH section also will showcase 5 clinical and
translational symposia of invited leaders in their ﬁelds.
Sunday, May 22, 2016: “Gut Microbiome in Pediatric
Gastrointestinal Diseases” and “Circadian Dysrhythmia in
Digestive Health and Disease.”
Monday, May 23, 2016: “Innovative Approaches to
Curing Intestinal Failure: The Future of Cell and Tissue
Therapy”
“Food Related Gastrointestinal Conditions” includes
“Food Allergies and Eosinophilic Esophagitis” (Chris Lia-
couras), “Gluten Hypersensitivity” (Alessio Fasano), and
“Inﬂuence of Diet on Irritable Bowel Syndrome and Func-
tional Abdominal Pain” (Carlo Di Lorenzo).
“Updates on Inﬂammatory Bowel Disease in Children”
includes “Current and Emerging Biologics for Pediatric IBD
[Inﬂammatory Bowel Disease]” (Jeff Hyams), “Very Early
Onset IBD” (Aleixo Muise), “Therapeutic Role for Fecal
Microbiome Transplantation in Pediatric IBD” (David Sus-
kind), and “Measuring and Improving Quality of Care in
Pediatric IBD” (Wallace Crandall).
Poster Sessions
The GDCH section planned 6 poster sessions. The topics
include the following: “Pediatric IBD: Clinical and Trans-
lational Studies,” “Pediatric Gut Microbiome and Microbi-
ology,” “Molecular Mechanisms of Growth, Differentiation,
and Disease,” “Clinical Pediatric Gastroenterology,”
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Functional and Motility Disorders.”
Immunology, Microbiology, and
Inﬂammatory Bowel Diseases Section
Edward V. Loftus, Jr, MD, AGAF, and
Mark S. Silverberg, MD, PhD
Introduction
The Immunology, Microbiology, and Inﬂammatory Bowel
Diseases (IMIBD) section covers important major scientiﬁc
topics such as innate and adaptive immunity, genetics and
the microbiome, animal models of IBD, mucosal immu-
nology, epithelial cell biology, and stem cells.
Research Fora
IMIBD will feature 18 research fora at DDW 2016.
Saturday, May 21, 2016: “Natural History and Outcomes
in Inﬂammatory Bowel Disease,” “Microbiome: Structure and
Function,” “Epidemiology of Inﬂammatory Bowel Disease,”
“Natural History and Outcomes in Inﬂammatory Bowel Dis-
ease II,” “IBD: Cytokines, Signaling and Receptors,” and
“Diagnostics in Inﬂammatory Bowel Disease.”
Sunday, May 22, 2016: “Identiﬁcation of Genes and
their Biology in IBD Pathogenesis,” “Quality of Life
and Psychosocial Care in Inﬂammatory Bowel Disease,” and
“Adverse Events Related to Therapy in Inﬂammatory Bowel
Disease.”
Monday, May 23, 2016: “Microbial Induced Mucosal
Inﬂammation and Immunity,” “’Biologic-Palooza’ in Inﬂam-
matory Bowel Disease,” “Basic Science Potpourri: Unique
Therapy Targets and Approaches to Understand IBD Path-
ogenesis,” and “Therapeutic Drug Monitoring in Inﬂamma-
tory Bowel Disease.”
Tuesday, May 24, 2016: “Controlled Clinical Trials in
Inﬂammatory Bowel Disease,” “IBD Target Development:
Pre Clinical Studies,” “Uncontrolled Therapeutic Observa-
tions in Humans with Inﬂammatory Bowel Disease,” “Dis-
ease Activity Assessment in Inﬂammatory Bowel Disease,”
and “Disease Complications in Inﬂammatory Bowel
Disease.”
Distinguished Abstract Plenary
IMIBD will showcase the best abstracts at the Distin-
guished Abstract Plenary on Monday, May 23, 2016. In the
middle of the session, the section leaders will present the
section Research Mentor Award to William J. Sandborn, MD,
AGAF.
The poster hall will feature more than 600 posters
submitted to the IMIBD section. Topics include the
following: “IBD: Adverse Events Related to Therapy,” “IBD:
Comparative Effectiveness Studies,” “IBD: Controlled Clin-
ical Trials in Humans,” “IBD: Diagnostics in IBD,” “IBD:
Disease Activity Assessment,” “IBD: Disease Complications,”
“IBD: Epidemiology,” “IBD: Natural History and Outcomes,”
“IBD: Practice Management/Quality of Care/Quality Assur-
ance,” “IBD: Quality of Life/Psychosocial Care,” “IBD:Therapeutic Monitoring,” “IBD: Uncontrolled Therapeutic
Observations in Humans,” “Pediatric IBD: Clinical and
Translational Studies,” “Animal Models: Pre-Clinical Treat-
ment of Intestinal Inﬂammation,” “Epithelial Cell Function in
Inﬂammation,” “Fecal Transplant Research,” “IBD: Cyto-
kines, Signaling and Receptors,” “IBD: Genomics and Gene
Function,” “IBD: Innate and Adaptive Lymphoid Activation
and Regulation,” “Inﬂammation and GI Cancers,” “Mecha-
nisms of Fibrosis,” “Microbial-Induced Mucosal Inﬂamma-
tion and Immunity,” “Microbiome: Structure and Function,”
“Mucosal Innate Immune Function and Innate Host De-
fense,” “Prebiotics and Probiotics,” and “Stem Cell Biology.”
Symposia
IMIBD also programmed 4 symposia.
Saturday, May 21, 2016: “Kiron and Kamala Das Sym-
posium: Gut Bugs and Their Products: The Keys to Inﬂam-
matory Drive?”
Sunday, May 22, 2016: “Inﬂammatory Bowel Disease: Is
It Different Between East and West?”
Monday, May 23, 2016: “From Association to Function:
Translating IBD Genetics Research to Biology”
Tuesday, May 24, 2016: “Anti-Integrin Versus Anti-TNF
[Tumor Necrosis Factor] for IBD: Steel Cage Match”
Intestinal Disorders Section
Nicholas O. Davidson, MD, AGAF, and
Wayne I. Lencer, MD, AGAF
Introduction
The Intestinal Disorders (ID) section represents a com-
munity of clinical, translational, and basic scientists inter-
ested in disease-focused and pathway-driven processes
underlying celiac disease; radiation- and chemotherapy-
induced injury; diarrhea and malabsorption; microbial
pathogenesis and mechanisms of microbe host cross-talk;
nutrient, salt, and water transport; epithelial barrier func-
tion and wound repair; and epithelial functions in innate
immunity. We aim to foster collaborations among interac-
tive scientiﬁc communities by featuring outstanding basic,
translational, and clinical research in these areas. These core
values and goals are reﬂected in our programing at DDW.
Research Fora
For DDW 2016, the ID section is sponsoring and co-
sponsoring the following research fora:
Saturday, May 21, 2016: “Understanding the Microbial
Host Interaction” (Chairs: Jonathan Jacobs and Nicholas O.
Davidson), “Inﬂammation, Injury and Repair Mechanisms in
the Gut” (Chairs: Peter Higgins and Georg Lamprecht), and
“Host Commensal Microbes, Cross-Talk and Synergy”
(Chairs: Gary D. Wu and Neelendu Dey).
Sunday, May 22, 2016: “Genetic Pathways Regulating
Intestinal Epithelial Damage, Repair and Death” (Chairs:
Matthew A. Ciorba and Florian Rieder) and “Intestinal
Epithelial Barrier Function and Wound Repair” (Chairs:
Asma Nusrat and Prashant Nighot).
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Injury and Tumorigenesis: In Vivo (Non-Human) Models of
Gastrointestinal Disorders” (Chairs: Scott Magness and
Yatrik Shah), “Ion Transport” (Chairs: Pawel R. Kiela and
Pradeep K. Dudeja), “New Insights Into Intestinal Adapta-
tion and Short Bowel Syndrome” (Chairs: Julian R. Walters
and Deborah C. Rubin), and “Bile Acids as Signaling Medi-
ators in Intestinal Disease” (Chairs: Jervoise Andreyev and
Paul A. Dawson).
Tuesday, May 24, 2016: “IBS [Irritable Bowel Syn-
drome] Pathophysiology” (Chairs: Yehuda Ringel and Greg-
ory S. Sayuk), “Gut Infections and Microbial Pathogenesis”
(Chairs: Beth McCormick and V. K. Viswanathan), “Celiac-
Clinical: Updates on Management of Celiac Disease” (Chairs:
Sheila E. Crowe and Dawn M. Wiese), and “Updates on Celiac
Disease: New Insights From Epidemiologic Studies” (Chairs:
Anneli Ivarsson and Stefano Guandalini).
Symposia
Saturday, May 21, 2016: “Understanding the Microbial
Host Interaction” will include “Antimicrobial Defense of the
Intestine” (Janelle Ayre), “Pattern Recognition Receptors
and Intestinal Microbial Defense” (David Artis), and “Gut
Epithelial Cell–Microbiota Interactions” (Andrew S. Neish).
Sunday, May 22, 2016: “Novel and Alternative Thera-
pies for Celiac Disease” will include “Rationale for Alterna-
tive Therapies” (Peter H. Green), “Targets for Treatment”
(Elena F. Verdu), “Current Status of Studies” (Joseph A.
Murray), and “Evaluation and Management of Refractory
Celiac Disease” (Ciaran P. Kelly).
Tuesday, May 24, 2016: “Updates on Acquisition and
Therapy of Clostridium difﬁcile” will include “Risk Factors
and Preventive Practice in 2016” (Erik R. Dubberke), “The
Beneﬁts and Risks of FMT for C diff” (Colleen R. Kelly), and
“Alternative Therapies for C diff: IVIG, Fidaxomicin, and
Beyond” (Krishna Rao).
State of the Art
Saturday, May 21, 2016: “Mechanisms of Intestinal
Restitution” (Thaddeus Stappenbeck).
Other Events
ID Business Meeting: The business meeting will be held
on Monday, May 23, 2016 from 5:45 to 6:45 pm in Room
33 of the convention center. This will follow ID_RFH_03:
New Insights into Intestinal Adaptation and Short Bowel
Syndrome.
Liver and Biliary Section
Jayant A. Talwalkar, MD, MPH, and
Kenneth E. Sherman, MD, PhD
Introduction
The membership of the Liver and Biliary (LB) section has
remained balanced over the past 2 years; as of January
2015, more than 4900 active members are afﬁliated with
the section, making it one of the largest sections. Domesticmembers comprise 67% of the section and international
members comprise 23%. More than 18% of the members
are trainees or young GIs. Other membership categories
include senior members, residents, and nurse practitioners/
physician assistants.
Although the section is not the current leader in liver-
biliary programming at DDW, we have made concerted ef-
forts to work with the American Association for the Study of
Liver Diseases to create joint programming for the beneﬁt of
our attendees.
Research Fora
The LB section is sponsoring 3 research fora, which will
have oral abstract presentations centered on general
themes. These include the following:
Saturday, May 21, 2016: “Liver and Biliary Carcinoma:
Management, Etiology, Diagnosis and Natural History.”
Tuesday, May 24, 2016: “Alcoholic and Non-Alcoholic
Steatohepatitis,” “Clinical Biliary Tract Disorders,” and
“Microbiome and Liver Disease.”
Symposia
Clinical Symposia: Three clinical symposia are being
sponsored independently or jointly with other AGA Institute
sections at DDW 2016.
The clinical symposium on Saturday, May 21, 2016, is
focused on “Controversies in Autoimmune Liver Disease.” A
panel of speakers will discuss topics including “Refractory
AIH (Michael Heneghan), “Overlap Syndromes with
PBC/PSC [Primary Biliary Cirrhosis/Primary Sclerosing
Cholangitis] (Marilyn Mayo), and “Recurrent Disease After
LT” (Aldo Montano-Loza). Autoimmune liver disease re-
mains a challenging diagnostic and management problem
for clinicians. This symposium will highlight those chal-
lenges and best approaches for management of these com-
plex patients.
The clinical symposium on Sunday, May 22, 2016, will
highlight the “Recent Advances in Acute on Chronic Liver
Failure (ACLF).” Topics include the following: “Deﬁnition
and Types of ACLF” (Jacqueline O’Leary), “Role of Infection
in ACLF” (Jasmohan Bajaj), and “Role of Surgery in ACLF”
(Patrick Kamath). Acute-on-Chronic Liver Failure frequently
is unrecognized. This symposium will highlight the clinical
issues in assessment and management of this difﬁcult entity.
The AGA Emmet B. Keeffe Symposium on Sunday, May
22, 2016, will tackle the topic of “Assessing Hepatic
Fibrosis–Truth, Lies and Wishes.” Topics include the
following: “Liver Biopsy and Computer Based Histo-
morphometry” (Zachary Goodman), “Laboratory Tests
that Predict Fibrosis Stage” (Richard Sterling), and
“Elastography-Shake Your Liver” (Nezam Afdhal). A world-
class group of speakers will honor the memory of Dr
Emmet Keeffe by bringing clarity to the world of hepatic
ﬁbrosis determination.
Research Symposia
Two research symposia hybrid sessions will incorporate
oral abstract presentations with invited talks.
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2016, is focused on “Hepatitis Prevention.” The session will
begin with the talk, “Treatment as Prevention–Breaking the
HCV [Hepatitis C Virus] Epidemic” (Carmilla Graham), fol-
lowed by this will be 2 abstract presentations and a period
for questions and answers. A growing hepatitis C virus
epidemic is spreading across the United States. This sym-
posium will examine ways to prevent hepatitis C and other
viral hepatitis infections.
Another research symposium hybrid on Monday, May
23, 2016, is focused on “Natural History of Viral Hepatitis,”
which will start off with “Hepatitis B–Stages, Transitions
and Outcomes” (Anna Lok), afterward, 3 abstract pre-
sentations will follow. Hepatitis B disease staging remains a
difﬁcult problem for clinicians. This symposium will high-
light new advances in our understanding of the natural
history of hepatitis B virus and other hepatitis viruses.
Translational Symposia
LB will feature 1 translational symposium that was
jointly programmed with other AGA Institute sections at
DDW 2016.
The translational symposium on Sunday, May 22, 2016,
will explore “Mediators of Inﬂammation and Fibrosis in the
Gastrointestinal Tract.” Topics include the following: “Not
Written in Stone: Modifying Hepatic Fibrosis” (Craig
McClain), “Common Pathways of Bowel Inﬂammation and
Scarring” (Claudio Fiocchi), “Intrinsic and Extrinsic Modi-
ﬁers of Esophageal Inﬂammation” (Rhonda Souza), and
“Pancreatic Inﬂammatory Processes-Changing the Course of
Disease” (Minolti Apte). Once thought to be immutable,
ﬁbrosis now is thought to represent a dynamic and plastic
process. This symposium will highlight recent advances in
the ﬁeld and look to the future for the direction of new
treatment modalities.
State of the Art
A highlight for LB is “The Dr. Charles S. Lieber Lecture—
New Frontiers: Transcriptional Factors in HCC [Hepatocel-
lular Carcinoma] Development,” which will be held on
Tuesday, May 24, 2016. The session will feature a talk
entitled, “Transcriptional Factors in HCC [Hepatocellular
Carcinoma] Development” by Jack Wands.
Poster Sessions
For DDW 2016, the LB section will offer multiple poster
presentation forums for accepted scientiﬁc abstracts. The
poster sessions will be divided into the following categories:
Saturday, May 21, 2016: “Complications of Cirrhosis
and Portal Hypertension” and “Metabolic and Genetic Liver
Disease.”
Sunday, May 22, 2016: “Liver and Biliary Carcinoma:
Management, Etiology, Diagnosis and Natural History.”
Monday, May 23, 2016: “Alcoholic and Non-Alcoholic
Fatty Liver Diseases” and “Pharmacoeconomics and Cost-
Effectiveness Analysis of Liver Disease.”
Tuesday, May 24, 2016: “Clinical Hepatitis: Etiology,
Diagnosis and Natural History,” “Microbiome and LiverDisease,” “Pediatric Liver and Biliary Diseases,” “Clinical
Hepatitis: Prevention and Treatment,” and “Clinical Biliary
Tract Disorders, Stone Diseases and Stone Pathogenesis.”
Neurogastroenterology
and Motility Section
Satish S. C. Rao, MD, PhD, AGAF, and
John Wiley, MD
Introduction
The Neurogastroenterology and Motility (NGM) section
is pleased to present some outstanding advances in basic,
translational, and clinical research at our San Diego meeting.
There have been signiﬁcant new developments in basic
science and mechanisms, novel therapeutic targets, several
reﬁnements of diagnostic techniques, and several promising
new drugs in the pipeline. At this DDW, the NGM section
offerings reﬂect the broad spectrum of scientiﬁc discovery,
innovation, and excitement, supplemented by a signiﬁcant
increase in abstract submissions. The NGM section received
503 abstracts and 396 were accepted, of which 84 will be
presented orally and the rest as posters.
Research Fora
There are several ground-breaking and novel research
fora in which cutting-edge science will be discussed. These
include joint sessions co-sponsored by other sections. We
introduce a novel feature of state-of-the-art lectures at the
end of each oral abstract session to summarize and bring
together the latest advances by an international expert in
the ﬁeld.
Saturday, May 21, 2016: “Novel Diagnosis and Treat-
ments for Functional Dyspepsia, Bloating and GERD,” “Ad-
vances in Cellular and Molecular Enteric Neurobiology,”
concluding with a state-of-the-art lecture entitled, “Novel
Animal Models for Enteric Neurobiology” by Dr Pankaj J.
Pasricha; “Emerging Paradigms in Enteric Sensory Neuro-
biology,” concluding with a state-of-the-art lecture entitled,
“Novel Targets for Treatment of Visceral Pain” by Dr Stuart
Brierley; and a novel session entitled “Advances in Enteric
Channels, Exchangers, and Transporters,” which will
conclude with a state-of-the-art lecture entitled, “Recent
Advances in Our Understanding of Endocannabinoids and
the Enteric Nervous System.”
Sunday, May 22, 2016: “Microbiota, FODMAP Diet, and
IBS” will include a state-of-the-art lecture by Dr William D.
Chey on “FODMAP and IBS.” “Clinical Advances in Swal-
lowing Disorders,” will conclude with a state-of-the-art
lecture entitled, “Esophagogastric Junction Morphology
Assessment in Health and Disease and Implications for
Management” by Dr Peter Kahrilas. Another outstanding
session entitled, “Diagnosis and Advances in Understanding
and Management of Irritable Bowel Syndrome,” will
conclude with a state-of-the-art lecture entitled, “Diagnostic
Testing in IBS: Looking Through the Crystal Ball” by Dr
Brennan Spiegel. Finally, “Gastric and Small Bowel Motility
and Dysmotility,” will conclude with a state-of-the-art
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Nausea,” by Dr William Hasler.
Monday, May 23, 2016: “Brain and Gut–Are They
Talking?” This session will include a state-of-the-art lecture
by Dr Qasim Aziz on this topic.
Tuesday, May 24, 2016: “Anorectal Disorders: Bench to
Bedside” will include a state-of-the-art lecture by Dr Adil
Bharucha on “Newer Diagnostic Tests for Anorectal Disor-
ders: How Useful?” Also, we have “Constipation and Colonic
Motility: What’s New?,” which will conclude with a state-of-
the-art lecture entitled, “Opioid-Induced Constipation: Who,
Why, and How to Manage” by Dr Ashok Tuteja. Another
exciting session is entitled, “Gastroparesis: Bench to
Bedside,” and will conclude with a state-of-the-art lecture
entitled, “Advances in Pathophysiology and Diagnosis of
Gastroparesis” by Dr Henry Parkman. Finally, we will co-
sponsor a pediatric forum entitled, “From Neonates to
Adults: Keeping the Gut Moving.”
Distinguished Abstract Plenary
On Monday, May 23, 2016, do not miss the best and
most outstanding research in the ﬁeld that will be presented
at this NGM distinguished plenary session. Attendees will
be able to listen and deliberate the most signiﬁcant ad-
vances from bench to translational to clinical neuro-
gastroenterology and motility. In addition, they will see the
presentation of the 2016 Research Mentor Award to Jackie
D. Wood, PhD, AGAF, RFF.
Symposia
The NGM section is sponsoring several research, trans-
lational, and clinical symposia that feature expert invited
speakers and hot topics in neurogastroenterology and
motility.
Building on a very successful program last year, on
Monday, May 23, 2016, we again will use a new format of
active audience participation and discussion centered on
controversies and questions in clinical motility. Drs Peter
Kahrilas, William Chey, and Satish Rao will chair the session
entitled, “Motility Matters: An Interactive Forum to Debate
What Progress the Field Has Made.” This symposiumwill use
a debate format with a panel led by a moderator to discuss
new diagnostic modalities in motility disorders, pathophysi-
ological correlates of symptoms in patients with functional
and motility disorders, and critically evaluate the efﬁcacy of
newer approaches to treatment of motility disorders.
Another excellent clinical symposium on Sunday, May
22, 2016, entitled “New Concepts in Esophageal Physiology:
The Role of Esophageal Wall Mechanics in Symptom Gen-
eration” will explore the pathogenesis of symptoms,
esophageal biomechanics, and ﬂow dynamics and cellular
and molecular mechanisms for esophageal pain, and will be
chaired by Drs Benson Massey and Abraham Khan.
The research symposium on Saturday, May 21, 2016,
will be “Glia, ICC [Interstitial Cells of Cajal], and Smooth
Muscle: Emerging Concepts and Future Directions.” This
state-of-the-art symposium chaired by Drs James Galligan
and Fievos Christoﬁ will bring experts in the ﬁeld to discusstheir groundbreaking research on the role of glia in neuro-
muscular function in health and disease, the role of inter-
stitial cells of Cajal, and what is new in smooth muscle, and
inform us about new directions we need to take and where
the next generation of discoveries will come from.
This year’s ﬁrst translational symposium will be on
Saturday, May 21, 2016, and will focus on “Bacterial Me-
tabolites in Gastrointestinal Diseases.” Chaired by Drs Purna
Kashyap and Elena Verdu, this innovative session will
feature a discussion on the role of metagenomics, SCFA, and
bacterial metabolites in the pathogenesis of IBS, IBD,
obesity, and colon cancer, and how D-lactic acidosis, brain
fogginess, and bacterial overgrowth may be linked.
The second translational symposium also will be held on
Saturday, May 21, 2016, and will be entitled, “The Brain-
Gut Axis–Novel Onsights from Translational Research.”
This exciting symposium chaired by Drs John Wiley and
Emeran Mayer will articulate what is new in our under-
standing of the brain and gut axis as it relates to functional
brain imaging, discuss the importance of these imaging
techniques in functional pain disorders, and, importantly,
examine the signiﬁcance of performing reverse translational
studies and test potential therapeutic interventions.
Poster Sessions
The poster sessions remain extremely popular with
attendees and will cover a wide range of cutting-edge topics.
Sessions will be held every day from Saturday, May 21 to
Tuesday, May 24, 2016, and will cover an array of topics.
Saturday, May 21, 2016: Topics covered will include the
following: Enteric Neurobiology: Cell and Molecular Biology;
Enteric Neurobiology: Pharmacology and Physiology;
Esophageal Motility and Dysmotility; and Functional
Dyspepsia, Nausea, and Vomiting.
Sunday, May 22, 2016: Topics covered will include the
following: Brain-Gut Axis; Constipation and Other Func-
tional Colonic Syndromes; and Sensory Neurobiology
including Visceral Nociception/Pain and Neuroimmunology.
Monday, May 23, 2016: Topics covered on this day will
include the following: Gastroparesis, and Irritable Bowel
Syndrome: Clinical.
Tuesday, May 24, 2016: Posters presented on this day
will include the following: Anorectal Dysmotility; Irritable
Bowel Syndrome: Pathophysiology; Oropharyngeal Dysmo-
tility; Pediatric Functional and Motility Disorders; and Small
Bowel Motility, Intestinal Disorders, and Food Intolerance.
Obesity, Metabolism, and
Nutrition Section
Dennis D. Black, MD, AGAF, and
Sandeep Gupta, MD, FASGE
Introduction
In recent years, DDW programming by the Obesity,
Metabolism, and Nutrition (OMN) section has emphasized
subject areas that have appealed to a majority of meeting
attendees, especially those afﬁliated not only with the OMN
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mon interests, as reﬂected by our strong participation in
cross-sectional programming. A major emphasis on obesity
and nutritional and metabolic disorders was solidiﬁed by a
section name change in 2013 to “Obesity, Metabolism, and
Nutrition,” reﬂecting a research and clinical focus on this
spectrum of major health problems. New programming has
included fora and symposia highlighting related topics,
including bariatric surgery and its impact on nutritional
status, GI neuroendocrinology and metabolism, new and
innovative endoscopic and other treatments of obesity and
diabetes, fatty liver disease, GI regulation of energy balance,
weight and metabolic function, microbiota and metabolic
regulation, and nutrition and metabolism across the life
cycle. Nutritional support in all of its forms used in the
management of a variety of diseases, including obesity, in-
testinal failure, and inﬂammatory bowel disease, as well as
nutrient absorption and metabolism, also have continued to
be the focus of OMN programming. The OMN section also
has endeavored to strike a balance between basic research
to shed light on disease mechanisms, including preclinical
studies to develop new therapies, and clinical and trans-
lational research to better describe disease phenotypes and
test new therapeutic approaches. This year, with the
approval by the Food and Drug Administration of new
endoscopic bariatric devices, we are emphasizing the use
and effectiveness of these approaches in several sessions.Research Fora
For DDW 2016, the OMN section is sponsoring 6
research fora, each with a focused theme and encompassing
basic and translational research. These include the
following.
Saturday, May 21, 2016: “Obesity: Clinical and Epide-
miological Studies.” Studies will be presented on the path-
ophysiology and clinical features of human obesity and its
complications, as well as mechanisms and effectiveness of
therapeutic interventions.
“Obesity Treatment: New Endoscopic Approaches.” Ab-
stracts will be presented on the use of new endoscopic
bariatric procedures in obesity therapy, as well as their
effectiveness, complications, and limitations.
Sunday, May 22, 2016: “Regulation of Food Intake,
Energy Expenditure, and Metabolic Function.” Research
presented will involve brain-gut signaling networks that
regulate caloric intake, energy expenditure, and metabolic
function and the perturbations that occur in disease states,
including obesity and diabetes.
“Obesity: Non-Surgical Treatment Effectiveness and
Cost.” Abstracts will cover nonsurgical approaches to
obesity, including bariatric devices and pharmacotherapy,
and their effectiveness and economic impact.
Monday, May 23, 2016: “Obesity: Basic Studies.” Basic
research will be presented on the normal physiologic
regulation of mechanisms contributing to body mass and
metabolic state, as well as perturbations that occur in
obesity and diabetes, and amelioration by bariatric surgery
and other therapeutic approaches.Tuesday, May 24, 2016: “Nutrient and Vitamin Ab-
sorption and Metabolism.” Abstracts will cover new
research on the basic and clinical aspects of nutrient and
vitamin absorption in health and disease.Symposia
In addition to these research fora, the OMN section will
be sponsoring 4 themed symposia.
Saturday, May 21, 2016: “Intestinal Nutrient Trans-
porters as Endocrine Targets.” Presenters at this research
symposium will discuss how endocrine/paracrine signaling
inﬂuences nutrient transporters and how nutrient ﬂux
across the intestinal epithelium is important for normal
physiology and for the development of pathologic states.
Talks will include “Hepcidin Regulation of Intestinal Iron
Transport” (Elizabeta Nemeth), “Short-Chain Fatty Acid
G-Protein-Coupled Receptors and Colon Health” (Vadivel
Ganapathy), and “GI Hormone Regulation of Intestinal Lipid
Absorption and Metabolism” (Patrick Tso).
Sunday, May 22, 2016: “Obesity Treatment–Genes, Diets
and Resources.” This clinical symposium will inform par-
ticipants of the emerging role of “precision medicine” in the
management of obesity, as well as the most effective diet
and lifestyle interventions in the management of obesity in
adolescents and adults, and how to use local resources for
lifestyle modiﬁcation for obesity intervention. Presentations
include “Why Precision Medicine May Be the Future of
Obesity Treatment” (Molly Bray), “Which Comes First,
Overeating or Obesity?” (David Ludwig), and “Moving
Beyond the Kitchen–Helping Patients Creatively Navigate
Local Resources” (Joseph A. Skelton).
Monday, May 23, 2016: “Food as a Drug: Nutritional
Therapies of GI Disease.” This collaborative symposium will
cover the emerging study of variations in genes involved in
carbohydrate digestion/absorption to guide dietary therapy
in IBS, the role of dietary nutrients and dietary supplements
in IBD treatment, the role of enteral nutrition in the treat-
ment of intestinal failure, and the role of diet in the man-
agement of obesity, metabolic syndrome, and nonalcoholic
fatty liver disease. Topics include “Dietary Treatment of IBS:
Can Genetics Guide Personalized Dietary Therapy?” (Robert
Shulman), “Enteral Nutrition and Nutraceutical Supple-
ments for IBD: What Works and What Doesn’t?” (Gerard E.
Mullin), “Enteral Nutrition to Promote Intestinal Failure
Rehabilitation” (Jeffrey Rudolph), and “Diet and Metabolic
Regulation in Obesity, Insulin Resistance, and NAFLD
[Nonalcoholic Fatty Liver Disease]” (Rohit Kohli).
Tuesday, May 24, 2016: “Approach to Obesity in Chil-
dren: Not Just Small Adults.” This clinical symposium will
cover metabolic abnormalities and morbidities associated
with obesity in children and their relationship to nutrition,
genetics, and inﬂammation in the setting of the metabolic
syndrome, as well as describe the approach to treatment of
pediatric obesity, including the roles of nutrition, lifestyle
changes, pharmacotherapy, and bariatric surgery in a
multidisciplinary setting. Presentations include “Impact of
Genetics on Pathogenesis and Response to Treatment in
Pediatric Obesity” (Joan Han), “Metabolic Syndrome in
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Treatment of Pediatric Obesity (Miriam Vos), and “Role of
Bariatric Surgery in Obese Adolescents” (TBA).
State of the Art
The OMN section will feature one state-of-the-art lecture
session this year.
Sunday, May 22, 2016: “The Microbiome, Obesity, and
Diabetes: The Future for Translation to Human Disease.”
These 2 state-of-the-art lectures will highlight how recent
advances in elucidating the role of the gut microbiome in
obesity and diabetes are translating to new therapeutic
approaches. Lectures include “New Insights Into the Role of
the Microbiome in Obesity and Type 2 Diabetes” (Max
Nieuwdorp) and “The Gut Microbiome and Metabolic
Regulation: What’s New and Translatable to Obesity Treat-
ment” (Lee M. Kaplan).
Poster Sessions
Poster sessions scheduled for Saturday, May 21, 2016
through Tuesday, May 24, 2016, will cover an array of
topics, including “Regulation of Food Intake and Energy
Expenditure,” “Gut Microbiota and Metabolic Regulation,”
“Nutritional Support and Clinical Nutrition,” “GI Regulation
of Metabolic Function,” “New Therapies for Obesity: Pre-
Clinical and Clinical,” “Obesity: Clinical and Epidemiolog-
ical Studies,” “Surgical and Endoscopic Treatment of
Obesity,” “Vitamins and Micronutrients: Basic and Clinical,”
“Obesity: Basic and Mechanistic Studies,” and “Microbiota
and Intestinal Disease.”
Pancreatic Disorders Section
Matthew J. DiMagno, MD, and
Santhi S. Vege, MD, AGAF, FACG, FACP
Introduction
The Pancreatic Disorders (PAN) section of the AGA
Council has 2909 members, which is a 20% increase
compared with 2015. For DDW 2016, PAN received 273
abstracts, which represents an increase of 23% over 1 year
and 36% over 2 years. Abstract programming includes 40
(15%) accepted for oral presentation and 180 (66%)
accepted for poster presentation. Two abstracts were
selected for presentation at the AGA Presidential and Clin-
ical Plenary Session.
The PAN section members’ interests span from clinical
practice to clinical, translational, and basic science investi-
gation. Popular clinical and translational themes include
acute and chronic pancreatitis; pancreatic necrosis;
autoimmune pancreatitis; pancreatic cystic neoplasms,
IPMN, and neuroendocrine tumors; cancer; pancreatic
endoscopy and imaging; and pancreatic cancer risk factors,
biomarkers, and diagnosis.
Basic science and translational themes focus on basic
regulatory mechanisms and pathways relevant to popular
PAN clinical topics, including inﬂammation and injury,
immunology and ﬁbrosis, healing and regeneration, growth,and neoplasia. These basic interests are organized under 3
abstract descriptors, including: Pancreatic genetics, epige-
netics, physiology, cell biology, and pathobiology; Pancrea-
titis: inﬂammation, ﬁbrogenesis, and immunology; and
Microbiome and pancreatic disease.
Research Fora
For DDW 2016, the PAN section is sponsoring 5 research
fora, each with a focused theme pertaining to clinical,
translational, or basic research. These include the following.
Saturday, May 21, 2016: “Pancreatic Cystic Neoplasms.”
Sunday, May 22, 2016: “Acute Pancreatitis.”
Monday, May 23, 2016: “Pathobiology of the Pancreas.”
Tuesday, May 24, 2016: “Chemoprevention and Novel
Treatments of Pancreatic Cancer” and “Chronic
Pancreatitis.”
Do not miss 3 AGA-sponsored hybrid clinical research
fora featuring many PAN section abstracts and exciting
keynote speakers: “Clinical Trials: Preventing Post-ERCP
[Endoscopic Retrograde Cholangiopancreatography]
Pancreatitis and Treating Pancreatic Necrosis,” “Pancreatic
Cancer Screening,” and “Chemoprevention and Novel
Treatments of Pancreatic Cancer.” The PAN also cosponsors
the research fora “Carcinoid and Neuroendocrine Tumors.”
Poster Sessions
Poster sessions scheduled for Saturday, May 21, 2016,
through Tuesday, May 24, 2016, will cover an array of
topics. In response to universally positive feedback, poster
judging will be offered again at DDW 2016 and afford junior
presenters the exciting opportunity to engage with and
impress senior experts in the ﬁeld. Also, do not miss the
AGA-sponsored Poster Tour (ticketed event) on “Acute
Pancreatitis” led by Drs Mel Wilcox and Bechien Wu.
Saturday, May 21, 2016: “Pancreatitis: Inﬂammation,
Fibrogenesis, and Immunology” and “Pancreatic Cancer:
Risk Factors, Biomarkers, and Diagnosis.”
Sunday, May 22, 2016: “Pancreatic Cystic Neoplasms,”
“Pancreatic Disorders: Endoscopy and Imaging,” “Micro-
biome and Pancreatic Disease,” and “Clinical Acute Pancre-
atitis II.”
Monday, May 23, 2016: “Clinical Acute Pancreatitis I.”
Tuesday, May 24, 2016: “Clinical Chronic Pancreatitis,”
“Pancreatitis: Inﬂammation, Fibrogenesis, and Immu-
nology,” and “Pancreatic Genetics, Epigenetics, Cell Biology,
and Pathobiology.”
Symposia
For DDW 2016 the PAN section is sponsoring or
cosponsoring a Collaborative Global Topic Symposium, 3
translational symposia, and 4 clinical symposia.
The Collaborative Global Topic Symposium Saturday,
May 21, 2016, focuses on “Regenerative Medicine:
Emerging Therapy for Pancreatic and GI Tract Disorders”
and will highlight the key concepts and tools of regenerative
medicine and application to the pancreas and intestinal
tract. Topics include the following: “Nuclear Reprogram-
ming Factors: Mechanistic Players and Therapeutic Tools in
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scription Factors in Acinar, Ductal, and Endocrine Homeo-
stasis” (Francisco Real), “Acinar to Ductal Metaplasia in
Pancreas Regeneration” (Howard Crawford), and “Tissue
Regeneration of the GI Tract Using Stem Cell Derived
Organoids” (David Tuveson).
The translational symposium on Saturday, May 21,
2016, focuses on “Implications and Limitations for Genetic
Testing in Pancreatic Diseases,” a practical topic relevant to
clinical practice that examines important and inter-related
aspects of genetic testing in chronic pancreatitis and the
application of genetic and epigenetic tools to understanding
and treating pancreatic cancer. Topics include the following:
“Introductory Case: Sporadic PRSS1 Mutation in Patient
With Single Attack of Pancreatitis (Matthew DiMagno),
“Presentation of Research Mentor Award: David C. Whit-
comb, MD, PhD, AGAF” (Matthew DiMagno and Santhi Vege),
“View of the Geneticist–Classifying the Signiﬁcance of
Mutations” (Randall Brand), “Pro and Con of Genetic
Screening in Chronic Pancreatitis” (David C. Whitcomb),
“Genomic Analysis in Chronic Pancreatitis” (Andrew Rhim),
and “Epigenetics at the Intersection of Chronic Pancreatitis
and Pancreatic Cancer” (Raul Urrutia).
The clinical symposium on Sunday, May 22, 2016,
focuses on “Determining the Etiology of Patients Labeled
With Idiopathic Pancreatitis.” Topics include the following:
“Deﬁnition of Idiopathic Pancreatitis and Role of Pancreas
Divisum” (Matthew DiMagno), “Sphincter of Oddi Dysfunc-
tion” (Stuart Sherman), “Genetic Associations With Idio-
pathic Pancreatitis” (Nageshwar Reddy), and “INSPPIRE
Consortium: Prevalence of Idiopathic Pancreatitis in Infants
and Toddlers” (Aliye Uc).
The translational symposium Sunday, May 22, 2016,
focuses on “Novel Targets for Treating Acute Pancreatitis.”
Topics include the following: “Disrupting Neurogenic
Mechanisms of Inﬂammation” (Rodger Liddle), “Carbon
Monoxide Based Therapies for Acute Pancreatitis” (Aida
Habtezion), “Is TNF [Tumor Necrosis Factor]-a Signaling an
Appropriate Target in Acute Pancreatitis?” (George Perides),
“Targeting Acinar Ductal Metaplasia to Promote Tissue
Healing” (Maximillian Reichert), and “Where and When
Might These Novel Approaches Be of Clinical Value?” (Fred
Gorelick).
The second clinical symposium on Sunday, May 22,
2016, focuses on “Update: Medical Management of Auto-
immune Pancreatitis and IgG4-Related Sclerosing Chol-
angitis” and will be immediately followed by the “Pancreatic
Disorders Section Business Meeting.” This is a less common
but serious clinical situation with signiﬁcant morbidity that
warrants a multidisciplinary collaborative approach. Topics
include the following: “Deﬁnitions of Remission, Recrudes-
cence, and Relapse in AIP“ (Suresh Chari), “Using a Steroid
Trial in AIP: What Is the Role?” (Myung-Hwan Kim), “In-
duction and Maintenance of Remission in AIP: Role of Glu-
cocorticoids” (Kazuichi Okazaki), “Management of Relapses
and Maintenance of Remission: Role of Immunomodulators”
(Phil Hart), and “Management of Relapses and Maintenance
of Remission: Role of B-Cell Depletion Therapy” (Mark
Topazian).The PAN section also is cosponsoring a clinical sympo-
sium Sunday, May 22, 2016, focused on “Duodenoscope-
Associated Carbapenem-Resistant Enterobacteriaceae
Infections: Epidemiology, Regulations, and Best Practices.”
The PAN section is cosponsoring a clinical symposium
Monday, May 23, 2016, focusing on “Management of
Pancreatic Necrosis.”
The translational symposium on Tuesday, May 24, 2016,
focuses on “Update: Pain in Chronic Pancreatitis.” Topics
include the following: “Mechanisms of Visceral Pain in Chronic
Pancreatitis” (Chung Owyang), “Pain and Fibrosis: Targeting
TGF [Transforming Growth Factor] b as a Unifying Theme in
Chronic Pancreatitis” (Jay Pasricha), “Assessing Pain and
Opioid Dependence in Chronic Pancreatitis” (Claudia Camp-
bell), and “Treating Pain in Chronic Pancreatitis: Pharmaco-
logical and Non-pharmacological Approaches” (Marco Bruno).
The PAN section also is cosponsoring a translational
symposium on Tuesday, May 24, 2016, focused on
“Updated Understanding and Approach to Managing
Neoplastic Cysts/IPMNS of the Pancreas.”
Other Events
Beyond the research fora and symposia, there are plenty
of other exciting events happening in the PAN section at
DDW 2016.
Sunday, May 22, 2016: Do not miss the AGA Breakfast
with Experts (Drs Suresh Chari and Darwin Conwell)
focused on “Chronic Pancreatitis: Screening for Cancer and
Treating the Pain.” At 5:30 pm, catch up with PAN section
leaders and hear important updates and future plans for the
PAN section by attending the “Pancreatic Disorders Section
Business Meeting” (Room 31BC of the Convention Center),
beginning immediately after the clinical symposium focused
on “Update: Medical Management of Autoimmune Pancrea-
titis and IgG4-Related Sclerosing Cholangitis”.
Monday, May 23, 2016: Do not miss attending 1 of 2
breakfast sessions, either the AGA Breakfast with Experts
(Drs Elmunzer and Scheiman) focused on “Managing
Pancreatic Cysts–Myths and Guidelines,” or the AGA-
sponsored Focused Clinical Update on “Updates in Man-
agement of Chronic Pancreatitis” (Yadav). Also attend the
AGA Presidential and Clinical Plenary and hear pre-
sentations of 2 top-rated PAN section abstracts, “Detection
of Pancreatic High-Grade Dysplasia and Cancer Using Novel
Methylated DNA Markers: Discovery and Tissue Validation”
(Shounak Majumder), and “Molecular Markers Help Deﬁne
Cyst Type in the Pancreas: An International, Multicenter
Study of Over 300 Cysts” (Anne Marie Lennon). At 12 noon,
join Drs Mel Wilcox and Bechien Wu for the AGA-sponsored
Poster Tour of abstracts on “Acute Pancreatitis.”Conﬂicts of interest
The author discloses no conﬂicts.
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